Gestational Diabetes Mellitus - Page 2 - Medscape
Insulin resistance and its role in gestational diabetes mellitus (GDM) should be defined for the patient. GDM should be differentiated from types 1 and 2 diabetes mellitus. Treatment options ...
Awakening to the Dawn Phenomenon in Diabetes - Medscape
Nov 7, 2024 · In people without diabetes, plasma insulin tends to remain stable and consistent during the night, with a slight, transient increase in insulin secretion just before dawn. This …
Immune Checkpoint Inhibitors Cause of Type 1 Diabetes?
Mar 20, 2025 · It's adult-onset type 1, but adult-onset type 1 without much residual insulin secretion that needs to be treated very intensely from the beginning. Again, quality of life is …
GLP-1 and GLP-2 and Intestinal Lipoprotein Production - Medscape
GLP-1 promotes insulin secretion in a glucose-dependent manner and preserves pancreatic β-cell function. [] In addition to its proinsulinemic effects, GLP-1 has been shown to have …
Vildagliptin: A Novel Oral Therapy for Type 2 Diabetes Mellitus
Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus …
Combination Therapy for Patients With Type 2 Diabetes - Page 3
Glinides. Meglitinides such as repaglinide and nateglinide are prandial insulin releasers that stimulate rapid insulin secretion. [] Repaglinide (NovoNorm®, Prandin®, GlucoNorm®) is the …
Preserving Insulin Secretion in Type 2 Diabetes Mellitus - Medscape
Abstract and Introduction. Type 2 diabetes mellitus (T2DM) is a complex disease characterized by insulin resistance and a progressive decline in β-cell function and mass.
A Single Jog Can Improve Glucose Metabolism in Young Adults
Oct 21, 2024 · Blood glucose levels were measured, and insulin sensitivity and secretion were estimated using surrogate indices derived from OGTT glucose and insulin assays, including …
Tirzepatide Plus Contraceptives: What You Need to Know
Mar 7, 2025 · They bind to the GLP-1 receptor, resulting in an increase of insulin secretion, a decrease in glucagon secretion, and slower gastric emptying. Their impact on gastric emptying …
Can We Repurpose Obesity Drugs to Reverse Liver Disease?
Oct 28, 2024 · In particular, GLP-1 RAs help patients lose weight and/or control diabetes by mimicking the function of the gut hormone GLP-1, released in response to nutrient intake, and …